Translational regulation as a novel mechanism for the development of cellular drug resistance

J C Schmitz1, J Liu, X Lin

  • 1Department of Medicine and Pharmacology, Yale Cancer Center, Yale University School of Medicine and VA CT Cancer Center, VA CT Healthcare System, New Haven 06516, USA.

Cancer Metastasis Reviews
|February 8, 2002
PubMed

Insights

Cancer cells can develop drug resistance through translational regulation, affecting key proteins like thymidylate synthase and dihydrofolate reductase. Disruptions in this process accelerate the emergence of cellular drug resistance, impacting chemotherapy effectiveness.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cellular drug resistance is a major challenge in cancer chemotherapy.
  • Translational regulation is increasingly recognized as a key factor in cellular processes.

Purpose of the Study:

  • To review the role of translational regulation in modulating cancer drug resistance.
  • To highlight specific examples of translational control in key proteins.

Main Methods:

  • Literature review of studies on translational regulation in cancer.
  • Analysis of experimental data on thymidylate synthase, dihydrofolate reductase, and p53.
  • Examination of mechanisms leading to drug resistance.

Main Results:

  • Translational control significantly impacts the expression of critical proteins involved in drug metabolism and cell cycle regulation.
  • Evidence supports the role of translational regulation in thymidylate synthase, dihydrofolate reductase, and p53.
  • Disruptions in translational control can lead to rapid development of cellular drug resistance.

Conclusions:

  • Translational regulation represents a promising novel mechanism for overcoming cancer drug resistance.
  • Targeting translational control pathways could enhance the efficacy of cancer chemotherapy.

Related Concept Videos

Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...